News - Adasuve, ISTA Pharmaceutical

Filter

Popular Filters

Planned expansion of anti-psychotic drug throughout Europe

29-10-2013

Austrian drugmaker AOP Orphan and privately held Spanish drugmaker Ferrer Internacional are expanding…

AdasuveAOP OrphanEuropeFerrer InternacionalMarkets & MarketingNeurologicalPharmaceutical

Ferrer and Medivir join forces on Adasuve for Nordic markets

19-09-2013

Sweden’s Medivir (Nasdaq OMX: MVIR) and privately-held Spanish drugmaker Ferrer Internacional have…

AdasuveAlexza PharmaceuticalEuropeFerrer InternacionalLicensingMedivirNeurologicalPharmaceutical

Alexza deal with Teva sets stage for Adasuve, say analysts

23-05-2013

USA-based Alexza Pharmaceuticals' (Nasdaq: ALXA) US marketing deal with Israel-headquartered Teva Pharmaceutical…

AdasuveAlexza PharmaceuticalAZ-002FinancialLicensingNeurologicalPharmaceuticalTeva Pharmaceutical Industries

FDA sets PDUFA date for Alexza's resubmission for Adasuve

08-07-2012

Following two earlier rejections, the US Food and Drug Administration has now accepted Alexza Pharmaceuticals…

AdasuveAlexza PharmaceuticalFerrer InternacionalNeurologicalNorth AmericaPharmaceuticalRegulation

Alexza rockets on re-submission of Adasuve NDA

25-06-2012

USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) saw its shares soar 44.9% to close at $3.97 on Friday,…

AdasuveAlexza PharmaceuticalNeurologicalNorth AmericaPharmaceuticalRegulation

FDA again rejects Alexza's Adasuve, citing manufacturing deficiencies

07-05-2012

California, USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) revealed last week that it has received another…

AdasuveAlexza PharmaceuticalNeurologicalNorth AmericaPharmaceuticalRegulation

ISTA Pharma accepts $500 million bid from Bausch & Lomb; settles royalty dispute

27-03-2012

US ophthalmic drugmaker ISTA Pharmaceuticals (Nasdaq: ISTA), which rejected a hostile takeover bid from…

Bausch & LombBromdayISTA PharmaceuticalLicensingMergers & AcquisitionsOphthalmicsPharmaceuticalProlensaSenju PharmaceuticalXibrom

Valeant pulls out of deal with ISTA, which announces Beposone progress

31-01-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has withdrawn…

BeposoneISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalResearchRespiratory and PulmonaryValeant Pharmaceuticals

PDUFA goal date for Alexza’s Adasuve extended, as Public Citizen says drug should not be approved

25-01-2012

US drug firm Alexza Pharmaceuticals (Nasdaq: ALXA) says that the US Food and Drug Administration will…

AdasuveAlexza PharmaceuticalNeurologicalNorth AmericaPharmaceuticalRegulation

Valeant ups its bid for ISTA Pharma

17-01-2012

California, USA-based ophthalmology and allergy drug company ISTA Pharmaceuticals (Nasdaq: ISTA) says…

ISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalRespiratory and PulmonaryValeant Pharmaceuticals

ISTA Pharma rejects Valeant’s advances; Alexza could be for sale

19-12-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) has entered into another…

AdasuveAlexza PharmaceuticalISTA PharmaceuticalMergers & AcquisitionsNeurologicalOphthalmicsPharmaceuticalValeant Pharmaceuticals

FDA advisory panel backs Alexza antipsychotic drug

15-12-2011

The US Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee (PDAC) has voted…

AdasuveAlexza PharmaceuticalFinancialLoxapineNeurologicalPharmaceuticalRegulation

Company Spotlight

Fibrotech

Fibrotech

Back to top